Literature DB >> 29264788

Utility of inverse probability weighting in molecular pathological epidemiology.

Li Liu1,2,3,4, Daniel Nevo5,6, Reiko Nishihara2,3,6,7, Yin Cao2,8,9, Mingyang Song2,8,9, Tyler S Twombly1, Andrew T Chan7,8,9,10, Edward L Giovannucci2,6,10, Tyler J VanderWeele5,6, Molin Wang11,12,13, Shuji Ogino14,15,16,17.   

Abstract

As one of causal inference methodologies, the inverse probability weighting (IPW) method has been utilized to address confounding and account for missing data when subjects with missing data cannot be included in a primary analysis. The transdisciplinary field of molecular pathological epidemiology (MPE) integrates molecular pathological and epidemiological methods, and takes advantages of improved understanding of pathogenesis to generate stronger biological evidence of causality and optimize strategies for precision medicine and prevention. Disease subtyping based on biomarker analysis of biospecimens is essential in MPE research. However, there are nearly always cases that lack subtype information due to the unavailability or insufficiency of biospecimens. To address this missing subtype data issue, we incorporated inverse probability weights into Cox proportional cause-specific hazards regression. The weight was inverse of the probability of biomarker data availability estimated based on a model for biomarker data availability status. The strategy was illustrated in two example studies; each assessed alcohol intake or family history of colorectal cancer in relation to the risk of developing colorectal carcinoma subtypes classified by tumor microsatellite instability (MSI) status, using a prospective cohort study, the Nurses' Health Study. Logistic regression was used to estimate the probability of MSI data availability for each cancer case with covariates of clinical features and family history of colorectal cancer. This application of IPW can reduce selection bias caused by nonrandom variation in biospecimen data availability. The integration of causal inference methods into the MPE approach will likely have substantial potentials to advance the field of epidemiology.

Entities:  

Keywords:  Etiologic heterogeneity; Marginal structural model; Missing at random; Neoplasm; Selection bias; Unique disease principle

Mesh:

Substances:

Year:  2017        PMID: 29264788      PMCID: PMC5948129          DOI: 10.1007/s10654-017-0346-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  57 in total

1.  Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.

Authors:  K Lu; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.

Authors:  Shuji Ogino; Mohan Brahmandam; Mami Cantor; Chungdak Namgyal; Takako Kawasaki; Gregory Kirkner; Jeffrey A Meyerhardt; Massimo Loda; Charles S Fuchs
Journal:  Mod Pathol       Date:  2006-01       Impact factor: 7.842

3.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

Review 4.  Review of inverse probability weighting for dealing with missing data.

Authors:  Shaun R Seaman; Ian R White
Journal:  Stat Methods Med Res       Date:  2011-01-10       Impact factor: 3.021

Review 5.  Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

Authors:  Asad Umar; Vernon E Steele; David G Menter; Ernest T Hawk
Journal:  Semin Oncol       Date:  2015-09-10       Impact factor: 4.929

6.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

7.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.

Authors:  Mingyang Song; Reiko Nishihara; Molin Wang; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Kana Wu; Shuji Ogino; Zhi Rong Qian; Kentaro Inamura; Xuehong Zhang; Kimmie Ng; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Katsuhiko Nosho
Journal:  Gut       Date:  2015-01-15       Impact factor: 23.059

8.  Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

Authors:  Kentaro Inamura; Mingyang Song; Seungyoun Jung; Reiko Nishihara; Mai Yamauchi; Paul Lochhead; Zhi Rong Qian; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Atsuhiro Masuda; Yu Imamura; Xuehong Zhang; Michael N Pollak; Christos S Mantzoros; Curtis C Harris; Edward Giovannucci; Charles S Fuchs; Eunyoung Cho; Andrew T Chan; Kana Wu; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2015-11-23       Impact factor: 13.506

9.  Molecular pathological epidemiology gives clues to paradoxical findings.

Authors:  Reiko Nishihara; Tyler J VanderWeele; Kenji Shibuya; Murray A Mittleman; Molin Wang; Alison E Field; Edward Giovannucci; Paul Lochhead; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2015-10-07       Impact factor: 8.082

10.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Authors:  Paul Lochhead; Aya Kuchiba; Yu Imamura; Xiaoyun Liao; Mai Yamauchi; Reiko Nishihara; Zhi Rong Qian; Teppei Morikawa; Jeanne Shen; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

View more
  32 in total

1.  Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Authors:  Tsuyoshi Hamada; Li Liu; Jonathan A Nowak; Kosuke Mima; Yin Cao; Kimmie Ng; Tyler S Twombly; Mingyang Song; Seungyoun Jung; Ruoxu Dou; Yohei Masugi; Keisuke Kosumi; Yan Shi; Annacarolina da Silva; Mancang Gu; Wanwan Li; NaNa Keum; Kana Wu; Katsuhiko Nosho; Kentaro Inamura; Jeffrey A Meyerhardt; Daniel Nevo; Molin Wang; Marios Giannakis; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs; Reiko Nishihara; Xuehong Zhang; Shuji Ogino
Journal:  Eur J Cancer       Date:  2018-09-13       Impact factor: 9.162

2.  Dietary intake of fiber, whole grains and risk of colorectal cancer: An updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts.

Authors:  Xiaosheng He; Kana Wu; Xuehong Zhang; Reiko Nishihara; Yin Cao; Charlie S Fuchs; Edward L Giovannucci; Shuji Ogino; Andrew T Chan; Mingyang Song
Journal:  Int J Cancer       Date:  2019-05-21       Impact factor: 7.396

Review 3.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

4.  Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.

Authors:  Fei Heng; Yanqing Sun; Seunggeun Hyun; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2020-04-09       Impact factor: 1.588

Review 5.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

6.  Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.

Authors:  Juha P Väyrynen; Mai Chan Lau; Koichiro Haruki; Sara A Väyrynen; Jeffrey A Meyerhardt; Marios Giannakis; Shuji Ogino; Jonathan A Nowak; Andressa Dias Costa; Jennifer Borowsky; Melissa Zhao; Kenji Fujiyoshi; Kota Arima; Tyler S Twombly; Junko Kishikawa; Simeng Gu; Saina Aminmozaffari; Shanshan Shi; Yoshifumi Baba; Naohiko Akimoto; Tomotaka Ugai; Annacarolina Da Silva; Mingyang Song; Kana Wu; Andrew T Chan; Reiko Nishihara; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2020-05-21       Impact factor: 12.531

Review 7.  Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Danny A Milner; Reiko Nishihara
Journal:  Annu Rev Pathol       Date:  2018-08-20       Impact factor: 23.472

8.  Calcium Intake and Survival after Colorectal Cancer Diagnosis.

Authors:  Wanshui Yang; Yanan Ma; Stephanie Smith-Warner; Mingyang Song; Kana Wu; Molin Wang; Andrew T Chan; Shuji Ogino; Charles S Fuchs; Vitaliy Poylin; Kimmie Ng; Jeffrey A Meyerhardt; Edward L Giovannucci; Xuehong Zhang
Journal:  Clin Cancer Res       Date:  2018-12-13       Impact factor: 12.531

9.  Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II.

Authors:  Mia M Gaudet; Emily Deubler; W Ryan Diver; Samantha Puvanesarajah; Alpa V Patel; Ted Gansler; Mark E Sherman; Susan M Gapstur
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

10.  Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.

Authors:  Koichiro Haruki; Keisuke Kosumi; Tsuyoshi Hamada; Tyler S Twombly; Juha P Väyrynen; Sun A Kim; Yohei Masugi; Zhi Rong Qian; Kosuke Mima; Yoshifumi Baba; Annacarolina da Silva; Jennifer Borowsky; Kota Arima; Kenji Fujiyoshi; Mai Chan Lau; Peilong Li; Chunguang Guo; Yang Chen; Mingyang Song; Jonathan A Nowak; Reiko Nishihara; Katsuhiko Yanaga; Xuehong Zhang; Kana Wu; Susan Bullman; Wendy S Garrett; Curtis Huttenhower; Jeffrey A Meyerhardt; Marios Giannakis; Andrew T Chan; Charles S Fuchs; Shuji Ogino
Journal:  J Pathol       Date:  2020-02-03       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.